Clinical Trials
3
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis
Phase 2
Not yet recruiting
- Conditions
- Ulcerative Colitis (UC)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Guangzhou Zhiyi Biotechnology Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT06725017
A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D
Phase 3
Recruiting
- Conditions
- Irritable Bowel Syndrome With Diarrhea
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Guangzhou Zhiyi Biotechnology Co., Ltd.
- Target Recruit Count
- 1298
- Registration Number
- NCT06247046
- Locations
- π¨π³
Wuxi People's Hospital, Wuxi, Jiangsu, China
π¨π³Binzhou Medical University Hospital, Binzhou, Shandong, China
A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Guangzhou Zhiyi Biotechnology Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06026397
- Locations
- πΊπΈ
Early Phase Clinical Unit (EPCU) - PAREXEL, Glendale, California, United States
News
No news found